Oxford Biomedica signs agreement to acquire ABL Europe
Oxford, UK – 4 December 2023: Oxford Biomedica, a quality and innovation-led cell and gene therapy CDMO, announces that it has entered into a sale and purchase agreement with Institut Mérieux, for the acquisition of ABL Europe, a Group’s company … Continued
Oxford Biomedica and Institut Mérieux enter into exclusive negotiations for the proposed acquisition of ABL Europe
Oxford Biomedica, a leading quality and innovation-led cell and gene therapy CDMO (“Contract Development Manufacturing Organisation”) and Institut Mérieux announce that they have entered into exclusive negotiations concerning Oxford Biomedica’s proposed acquisition of ABL Europe, a Group’s company specialized in … Continued
Abdoulaye Djimdé, winner of the 2023 Christophe Mérieux Prize
Abdoulaye Djimdé receives the Christophe Mérieux 2023 Prize from Fondation Christophe et Rodolphe Mérieux – Institut de France Professor of Parasitology and Mycology in Mali, Professor Abdoulaye Djimdé is rewarded for his research program using molecular and genomic approaches to … Continued
GeNeuro press conference on long-COVID
On March 14, 2023, Institut Mérieux hosted a GeNeuro press conference on long-COVID, a major public health issue. Institut Mérieux is a reference shareholder of GeNeuro and follows with interest the development of this Franco-Swiss company, a bioMérieux spin-off created … Continued
International Prize in Planetary Health awarded to Dr. Guilherme Dias de Melo of the Institut Pasteur
The International Prize in Planetary Health was awarded this Wednesday, October 12, 2022 in Lyon to Dr. Guilherme Dias de Melo of the Institut Pasteur for his work on neurotropic viral infections and their transmission from animals to humans.This prize … Continued
